Vaxxa AB (NGM:VAXXA)

Vaxxa AB Statistics

Total Valuation

Vaxxa AB has a market cap or net worth of SEK 25.93 million. The enterprise value is 17.72 million.

Market Cap	25.93M
Enterprise Value	17.72M

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Vaxxa AB has 43.37 million shares outstanding. The number of shares has increased by 35.31% in one year.

Current Share Class	43.37M
Shares Outstanding	43.37M
Shares Change (YoY)	+35.31%
Shares Change (QoQ)	+2.80%
Owned by Insiders (%)	3.45%
Owned by Institutions (%)	n/a
Float	41.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.38
PB Ratio	1.20
P/TBV Ratio	1.45
P/FCF Ratio	76.28
P/OCF Ratio	74.10
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.25
EV / Sales	0.26
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	52.11

Financial Position

The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.03.

Current Ratio	5.91
Quick Ratio	5.27
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	1.66
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.30% and return on invested capital (ROIC) is -11.39%.

Return on Equity (ROE)	-17.30%
Return on Assets (ROA)	-9.55%
Return on Invested Capital (ROIC)	-11.39%
Return on Capital Employed (ROCE)	-16.78%
Revenue Per Employee	7.59M
Profits Per Employee	-375,333
Employee Count	8
Asset Turnover	2.86
Inventory Turnover	1,790.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.01% in the last 52 weeks. The beta is 0.81, so Vaxxa AB's price volatility has been lower than the market average.

Beta (5Y)	0.81
52-Week Price Change	-54.01%
50-Day Moving Average	0.61
200-Day Moving Average	0.79
Relative Strength Index (RSI)	49.35
Average Volume (20 Days)	52,034

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaxxa AB had revenue of SEK 68.35 million and -3.38 million in losses. Loss per share was -0.07.

Revenue	68.35M
Gross Profit	-2.39M
Operating Income	-3.66M
Pretax Income	-3.38M
Net Income	-3.38M
EBITDA	-1.58M
EBIT	-3.66M
Loss Per Share	-0.07

Balance Sheet

The company has 8.78 million in cash and 566,000 in debt, giving a net cash position of 8.22 million or 0.19 per share.

Cash & Cash Equivalents	8.78M
Total Debt	566,000
Net Cash	8.22M
Net Cash Per Share	0.19
Equity (Book Value)	21.58M
Book Value Per Share	0.50
Working Capital	9.63M

Cash Flow

In the last 12 months, operating cash flow was 350,000 and capital expenditures -10,000, giving a free cash flow of 340,000.

Operating Cash Flow	350,000
Capital Expenditures	-10,000
Free Cash Flow	340,000
FCF Per Share	0.01

Margins

Gross margin is -3.50%, with operating and profit margins of -5.35% and -4.94%.

Gross Margin	-3.50%
Operating Margin	-5.35%
Pretax Margin	-4.94%
Profit Margin	-4.94%
EBITDA Margin	-2.31%
EBIT Margin	-5.35%
FCF Margin	0.50%

Dividends & Yields

Vaxxa AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.31%
Shareholder Yield	-35.31%
Earnings Yield	-13.03%
FCF Yield	1.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	Mar 14, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

Vaxxa AB has an Altman Z-Score of 15.17 and a Piotroski F-Score of 4.

Altman Z-Score	15.17
Piotroski F-Score	4